CDKAL1 and gestational diabetes: Thus, in the present trial sequential meta-analysis, we confirmed the association between CDKAL1 polymorphisms rs7756992 or rs7754840 with the risk of GDM under the allele models, and no more samples are needed to further evaluate these findings.